Prof. Sara Ramella, Professor of Radiation Oncology, Università Campus Bio-Medico di Roma

Bio
Sara Ramella is Professor of Radiation Oncology at Campus Bio-Medico University, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. She is Members of the Scientific Board of the PhD Course on Artificial Intelligence – Area Health & Life Sciences at Campus Bio-Medico University. He trained at the Università Cattolica del Sacro Cuore (UCSC), Fondazione Policlinico Universitario A. Gemelli IRCCS of Rome. Her main interest lies in lung cancer treatment with regard to combination of radiation and chemotherapy, target agents and immunotherapy. In the era of personalized medicine, her research has also focused on exploiting radiomics data in Non–Small Cell Lung Cancer (NSCLC). The academic age is 17 years, publications have collected 2240 citations, h-index is equal to 21 (Scopus, updated July 2022). She as an international teaching experience collaborating with European Society of Radiation Oncology for Lung Cancer Teaching Courses and she was ESTRO official delegate for some intersociety projects. She is actually the coordinator of the Lung Cancer subgroup ESTRO Guidelines and was track chair for WCLC 2022. She actually is Associate Editor of Journal of Thoracic Oncology and collaborated in the drafting of the IASLC Textbooks.
With regard to practical research applications characterized by a large degree of international collaborations. Her latest research is directed to develop a Radiomics-based Decision Support System (RDSSs) to predict outcomes during chemoradiation. Her efforts have been recognized by the University Strategic Project 2019 Award for the project “A Collaborative Multi-Sources RadioPathomics Approach for Personalized Oncology in NSCLC”.
Other awards and honors
– Project entitled “Valorisation of wastes from wineries through the recovery of active ingredients and development of formulations for ‘nutraceutical and food’ antimicrobial products from a circular economy perspective”, Lazio Innova; POR FESR Lazio 2014-2020.
– Coordinator on lung cancer guidelines ESTRO2022 (European SocieTy for Radiotherapy and Oncology)
– Track Chair Metastatic NSCLC Palliative Radiotherapy Track for World Lung Cancer Congress 2022
– Cochrane Lung Cancer Group Editor since September 2019.
– IASLC Delegate for ASTRO 2019 Guidelines on Small Cell Lung Cancer.
– AIOM working group on lung cancer guidelines from 2019 to now; mesothelioma 2016-2018 and bone metastases 2014- 2018.
– AIRO working group on lung cancer guidelines from 2019.
– Delegate of the AIRO President from 2015-2017.
– Coordinator of the lung cancer study group of the ROG (Radiation Oncology Group) EORTC 2014-2017 and treasurer ’15- ’17.
– ESTRO delegate for “The Thoracic Oncology HERMES (Harmonized Education in Respiratory Medicine for European Specialists) Task Force” 2015-2016.
– National Board of Directors of AIRO 2012-2015.
– Teacher of ESTRO Lung Cancer Courses from 2012

Presentation
This is one of the most innovative theme of the recent years. We’ll address the topic with the modern literature data of chemoradiation and considerations/suggestions on what we can expect in future for locally advanced NSCLC.